This compound is a modified nucleoside used as a building block in oligonucleotide synthesis. It features a purine base with an isobutyramide protecting group and a dimethoxytrityl (DMT) protecting group on the sugar moiety, which is typical for solid-phase DNA/RNA synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 114745-26-5
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine
nucleoside analog pharmaceutical intermediate
5'-O-DMT-2'-O-iBu-N-Bz-Guanosine
protected guanosine for oligonucleotide synthesis
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
Pharmaceutical intermediate for oligonucleotide synthesis
Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-N-(2-methyl-1-oxopropyl)-
Protected nucleotide building block for oligonucleotide synthesis
[1,1'-Biphenyl]-2-carboxylic acid, 4'-methyl-, methyl ester
pharmaceutical intermediate
Methyl 4'-(Bromomethyl)biphenyl-2-carboxylate
pharmaceutical intermediate
TERT-BUTYL 4'-(BROMOMETHYL)BIPHENYL-2-CARBOXYLATE
pharmaceutical intermediate
2-Cyano-4'-methylbiphenyl
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
ISQLJOGRNUQHJX-WIFIACMTSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OC